Pfizer Plans $650M Groton Plant to Make Drugs for Its Own Trials
Pfizer plans to build a new clinical manufacturing facility at its research and development campus in Groton, Connecticut. AdvanceCT, the state's nonprofit economic development group, announced the USD 650 million project on November 5, 2026.
What happened
According to AdvanceCT, Pfizer will spend the USD 650 million over the next five years. The building will cover about 220,000 square feet.
The site will make clinical active pharmaceutical ingredients and finished drug products. These will supply Pfizer-sponsored clinical trials around the world, the release said.
- Construction: planned to start in the second quarter of 2027.
- Startup: operations are targeted for mid-2031.
- Staff: the facility will bring together employees who now work in other buildings on the Groton campus.
Raja Mangipudy, the Groton site head, pointed to the company's long history of science in the town. Connecticut's economic development commissioner, Daniel O'Keefe, called the investment an endorsement of the strong momentum in the state's economy.
Why it matters
Groton is one of Pfizer's major research centres, Pharma Manufacturing reported. The trade outlet noted that the company's pipeline includes 89 candidates.
The plan also follows Pfizer's September 2025 agreement with the US government. Under that deal, Pfizer pledged USD 70 billion in US research and manufacturing investment, Pharma Manufacturing reported. The deal also covered lower drug prices and a three-year pause on pharma-specific tariffs.
At the same time, Pfizer is cutting costs. Its chief financial officer said the company is on track to deliver nearly all of an expected USD 7.2 billion in net savings by the end of 2026.
What it means for people in the industry
None of the sources gives a count of new jobs. AdvanceCT said the facility will consolidate staff already working on the campus. It did not give a hiring target.
The Groton campus employs about 2,700 people, according to the Connecticut Business and Industry Association. The project could matter for engineers, construction firms and suppliers in the region during the build, ahead of a targeted mid-2031 startup.
Things to watch include the final design and whether Pfizer adds roles closer to startup. Clinical supply, process development and quality staff may want to follow updates from the Groton site.
See open pharma jobs in the US and Canada
Sources
Check Your Supplement Interactions
Use our AI-powered checker to analyze supplement safety and interactions.
Open Interaction Checker →Comments (0)
This article is for informational purposes only and does not constitute medical or investment advice. It was written with AI assistance from the sources listed above. Check the original sources before relying on any detail.